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Background: Endoscopic submucosal dissection (ESD) has typically been performed using air insufflation. Recently,
however, insufflation of CO2 has been increasingly used to avoid complications. This prospective study was designed to
compare the CO2 concentration, intestinal volume, and acid–base balance using the duodenal balloon procedure.
Methods: From June 2010 to February 2011, we enrolled 44 patients with esophageal or gastric cancer and randomly
allocated them into two groups. We compared 22 patients undergoing CO2-insufflated ESD with a balloon placed into
the duodenal bulb (duodenal balloon group) and 22 patients undergoing regular CO2-insufflated ESD (regular group).
Three-dimensional computed tomography was performed before and after the procedure to measure intestinal
volume. CO2 concentrations were measured every 10 minutes. The visual analogue system (VAS) scores for
postoperative symptoms were recorded, and pH was measured immediately after the procedure. This was a
prospective case control study randomized by the sealed envelope method.
Results: Intestinal CO2 gas volume before and after ESD was lower in the duodenal balloon group than in the regular
group (P=0.00027). The end-tidal CO2 level was significantly lower in the duodenal balloon group than in the regular
group (P=0.0001). No significant differences in blood ΔpH were found between the two groups. The VAS score for the
occurrence of nausea due to abdominal distension after ESD indicated a significant difference (P=0.031).
Conclusions: ESD using the duodenal balloon occlusion method is effective for reduction of post-ESD intestinal CO2
gas volume, resulting in a lower total amount of CO2 insufflation during ESD and reducing harmful influences on the
human body to some extent.Background
Endoscopic submucosal dissection (ESD) for gastrointes-
tinal malignancy has been increasingly performed in
Japan, and its technical basis is almost completely estab-
lished [1-4]. The procedure is also covered by the health
insurance system in Japan. However, ESD is technically
complicated [5,6], requires a high level of endoscopic* Correspondence: hiro4884@med.kagawa-u.ac.jp
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reproduction in any medium, provided the origskill, and has been associated with serious complications
[7,8]. Although insufflation of air has traditionally been
used in ESD, there are many risks, such as air embolism.
As an alternative to air, insufflation of CO2 has been
used in regular colonoscopy and colorectal ESD which
has been proven effective [9-17]. Insufflation of CO2 is
also available to help maintain a stable respiratory and
hemodynamic state during ESD by preventing pneumo-
peritoneum when perforation occurs [18-21] and redu-
cing post-ESD symptoms, such as nausea due to
abdominal distension. In addition, given recent issues. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
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tion of CO2 is expected to become increasingly more
common.
The present study was a prospective comparison of
changes in CO2 concentration during the procedure and
changes in intestinal volume and acid–base balance
using the duodenal balloon occlusion method.Methods
Patients
We enrolled 44 patients who were diagnosed with early
gastric or esophageal cancer and demonstrated expand-
ing indications for ESD by the gastric cancer treatment
guidelines of the Japanese Gastric Cancer Association
(JGCA). The expanding indications of ESD are as fol-
lows: mucosal differentiated adenocarcinoma of any size
without ulceration, SM1-invaded differentiated adeno-
carcinoma within 3 cm in diameter, and mucosal undif-
ferentiated adenocarcinoma within 2 cm in diameter
without ulceration. All patients underwent ESD using
CO2 insufflation.
We randomly allocated 44 patients (34 males and 10
females) who underwent ESD for early esophageal or
gastric cancer into two groups by the sealed enveloped
method from June 2010 to February 2011 (Table 1). The
exclusion criteria were a past history of a duodenal ulcer
or the presence of an ulcer scar.
We informed all patients of this study’s aim and
method. Full details of patients’ informed consents were
followings: using the balloon for esophageal variceal in-
jection sclerotherapy as duodenal occlusion balloon. An
overtube was used to allow backflow of CO2 gas from
the stomach to the oral cavity for evacuation from the
mouth, preventing the gas from flowing into the trachea
and lungs. Under putting the balloon, we would perform
ESD. We informed these procedures and side effects,Table 1 No significant differences were found with
respect to age, gender, location of lesion, diameter of


































*Fisher’s exact t-test, **Unpaired t-test, ***Mann–Whitney U-test.and obtained consents from all patients in written forms.
The study protocol was reviewed and approved by the
Kagawa university ethical committee according to the
Declaration of Helsinki. All subjects gave written,
informed consent before any study related procedures
were performed.
Study design
This was a single-center, randomized, case control study.
The objectives were to examine the intestinal CO2 gas
volume measured by three-dimensional computed tom-
ography (3DCT) before and after ESD using the duo-
denal balloon occlusion method and determine the effect
on certain parameters between in the duodenal balloon
group and regular group.
We performed ESD on 44 patients. We performed
CO2-insufflated ESD with a duodenal balloon in 22
patients (duodenal balloon group) and regular CO2-
insufflated ESD without the balloon in 22 patients (regu-
lar group). The duodenal balloon occlusion method is
described in following section. 3DCT was performed the
day before ESD and just after the ESD to measure intes-
tinal gas volume. CO2 concentrations were measured
every 10 minutes by a capnometer (end-tidal CO2;
PETCO2) every 10 min until the end of ESD ( from 0 to
120 min; however, if ESD was finished earlier, measure-
ment was terminated; if ESD lasted longer, measurement
was terminated at 120 min. that’s because under the
stable CO2 insufflation, ΔPETCO2 doesn’t change so
much ). Arterial blood gas pH was measured in both
groups just before ESD, and after ESD subsequently to
3DCT (about 15 minutes later after ESD finished). The
visual analogue system (VAS) scores for postoperative
symptoms were recorded after the procedure.
Duodenal balloon occlusion method
We used the balloon for esophageal variceal injection
sclerotherapy. We made a circular ring with a nylon
thread at the tip of the balloon to create a better grip,
grasped this circular ring with a gripping forceps, and
inserted it through the overtube into the duodenal bulb.
We infused an appropriate amount of air as calculated
for previous gastric fluoroscopy (60–70 mL on average)
to fix the balloon (Figure 1). During the procedure, an
overtube was used to allow backflow of CO2 gas from
the stomach to the oral cavity for evacuation from the
mouth, preventing the gas from flowing into the trachea
and lungs. This overtube with no valve could evacuate
the backflowing gas from the body.
3DCT (intestinal gas volume)
Reconstructions of 3DCT and measurements of intes-
tinal gas volume were performed and calculated by radi-
ology technician Dr. Masaomi Ohkubo. 3DCTs were
Figure 1 (A) A circular ring was made with a nylon thread at the tip of the balloon to create a better grip. (B) This circular ring was
grasped with a gripping forceps and inserted into the duodenal bulb. (C) The balloon was dilated with 60 to 70 mL of air. (D) The intragastric
insufflation tube was clipped onto the gastric wall to prevent the insufflation tube from interfering with the lesion to be removed.
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(VR) technique. The cut off level of VR was set at
-400HU. The voltage was 120 kV and the electric current
was 200 mA. Raw Slice thickening was 1 mm and recon-
struction was 0.8 mm, and using these parameters,the
accuracy of calculated intestinal volumes was 99.5%.Outcomes
The primary outcome was the intestinal volume mea-
sured by 3DCT before and after ESD using the duodenal
balloon occlusion method compared with that of the
regular group. The secondary outcome was the intra-
operative change in CO2 concentration between the two
groups as measured by a capnometer (end-tidal CO2;
PETCO2) every 10 min until the end of ESD. Differences
in arterial blood gas pH between the two groups were
measured immediately before and after ESD. Patients’
abdominal symptoms after ESD as scored using the VAS
ranged from 0 (no symptoms) to 10 (severe symptoms).Statistical analysis and sample size
The null hypothesis was that the intestinal CO2 gas
volumes measured by 3DCT before and after ESD using
the duodenal balloon occlusion method would be identi-
cal to those of the regular group.
A previous study using air insufflation with or without
duodenal balloon occlusion has been reported [22]. We
referred to the study and calculated the target number of
64 subjects per group based on G*Power using the ef-
fective size of 0.5. An effective size of 0.8 resulted in atarget number of 25. Based on these numbers, we
decided to use a target number of 44 to 45.
Randomizations and procedures
This was a single-center, randomized, case control study.
Patients were randomly allocated by the sealed envelope
method. The randomization was achieved using sealed
numbered envelopes, prepared previously by Dr. H. K.
The randomization code was not broken until the study
was completed. All investigators attended a study meet-
ing before the study and received instructions on per-
formance of the duodenal balloon occlusion method.
PETCO2 was recorded every 10 min from the start of
ESD to the end of ESD by nurses who were not notified
about this study. CT scans, reconstructions of 3DCT
images, and calculations of intestinal CO2 gas were per-
formed respectively by separate radiology technicians
who were not notified about this study.
All ESD procedures were performed by one JGES-
certified endoscopist (H. M.) with experience of more
than 150 cases annually. After all studies were finished,
the data were analyzed by Drs. S. F. and H. K. This pro-
spective clinical study was conducted after approval by
the institutional ethics committee of Kagawa University
Hospital and was enrolled with the University Hospital
Medical Information Network (ID: 000003742).
Patients’ baseline statistics were analyzed using the un-
paired t-test, Fisher’s exact test, and the Mann–Whitney
U-test. Statistical significance was accepted for P values of
<0.05. PETCO2 was analyzed every 10 min by repeated
measure ANOVA (Graph Pad Prism 5).
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Study population
A total of 44 subjects were enrolled in this study. One
subject did not continue treatment because of massive
bleeding during ESD. The remaining 43 subjects under-
went subsequent endoscopic treatments according to the
study protocol. Twenty-one subjects were randomlyFigure 3 The duodenal balloon group showed no significant differenc
(256.0 ± 124.4 mL) ESD. The regular group showed a significant difference
The Δvolume before and after ESD was significantly lower in the duodenal
(130.15 ± 86.52 mL) (P= 0.00027).
Figure 2 A total of 44 subjects were enrolled. One subject did
not continue treatment because of massive bleeding during
ESD. The remaining 43 subjects underwent subsequent endoscopic
treatments according to the study protocol. Twenty-one subjects
were randomly assigned to the duodenal balloon group and 22 to
the placebo (regular) group.assigned to the duodenal balloon group and 22 to the
placebo (regular) group. The allocation of the patients to
the study groups and reasons for exclusion are shown in
Figure 2. The baseline characteristics of the two groups
were well matched, and no significant differences were
found between the 43 patients with respect to age, gen-
der, location of lesion, size of resected lesion, or pro-
cedure time (Table 1).
Primary outcome
The duodenal balloon group showed no significant dif-
ference in intestinal volume before (213.4 ± 118.8 mL) or
after (256.0 ± 124.4 mL) ESD. On the other hand, the
regular group showed a significant difference before
(214.0 ± 29.85 mL) and after (350.9 ± 33.17 mL) ESD
(P=0.005). The amount of increase in intestinal volume
(Δvolume) before and after ESD was significantly lower in
the duodenal balloon group (25.14± 24.91 mL) than in the
regular group (130.15± 86.52 mL) (P=0.00027) (Figure 3).
Secondary outcomes
The PETCO2 level from 10 to 120 min after the start of
ESD was significantly lower in the duodenal balloon
group (22.1 ± 4.74 mmHg) than in the regular group
(46.6 ± 1.69 mmHg) (P= 0.0001) (Figure 4).
In terms of arterial blood gas analysis before and just
after ESD, pH of the duodenal balloon group showed no
significant difference (P= 0.423), but a significant differ-
ence was seen in the regular group (P= 0.037). The ΔpHe in intestinal volume before (213.4 ± 118.8 mL) or after
before (214.0 ± 29.85 mL) and after (350.9 ± 33.17 mL) ESD (P= 0.005).
balloon group (25.14 ± 24.91 mL) than in the regular group
Figure 4 The PETCO2 level from 10 to 120 min after the start of ESD was significantly lower in the duodenal balloon group
(22.1 ± 4.74 mmHg) than in the regular group (46.6 ± 1.69 mmHg) (P=0.0001).
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(P= 0.549) (Figure 5).
As shown in Figures 6 and 7, which depict Case 5
(duodenal group) and Case 36 (regular group), the intes-
tinal CO2 gas volume just before and after ESD was
lower in the duodenal balloon group than in the regular
group.
The VAS score for the occurrence of nausea due to
abdominal distension after ESD ranged from 0 to 1 in
the duodenal balloon group and from 3 to 7 in the regu-
lar group, revealing a significant difference (P = 0.031)
(Figure 8).Figure 5 The pH of the duodenal balloon group showed no significan
the regular group (P=0.037). The ΔpH showed no significant differenDiscussion
The advantage of CO2-insufflated ESD for early colorec-
tal cancer has been previously reported [10]. Complica-
tion associated with CO2 insufflation such as CO2
narcosis and gas embolism wasn’t seen [11]. Several
studies has been reported about the influences of CO2
insufflation on the human body during ESD of the upper
gastrointestinal (GI) tract, and it is well known that car-
bon dioxide is absorbed faster in the body than air and
also that it is rapidly excreted through respiration with-
out any complications [12]. And it is also reported that
insufflation of CO2 than air during esophageal ESDt difference (P=0.423), but a significant difference was seen in
ce between the two groups (P=0.549).
Figures 6 Duodenal balloon group: CT coronal image & 3D image. Two cases are depicted: Case 5 (duodenal balloon group) and Case 36
(regular group). 3DCT showed that the intestinal CO2 gas volume was relatively lower in the duodenal balloon group than in the regular group.
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sema [13]. In CO2-insufflated ESD for early colorectal
cancer, CO2 gas is insufflated retrogradely, Bauhin’s valve
functions as a backflow-prevention system, and the CO2
is absorbed only through the colonic mucosa.
In esophageal or gastric CO2-insufflated ESD, CO2 gas
insufflated into the upper GI tract is widely distributed
to and absorbed rapidly through not only the esophagus
and stomach, but also other parts of the GI tract, such as
the intestine. This suggests two potential effects of
esophageal or gastric CO2-insufflated ESD on the human
body.Figure 7 Regular group: CT coronal image & 3D image. Two cases are
group). 3DCT showed that the intestinal CO2 gas volume was relatively lowFirst, massive insufflated CO2 gas into the stomach,
duodenum, and intestine during or after ESD may
worsen patient symptoms such as nausea and abdominal
distension to some extent. Its volume effects may also in-
fluence patients’ respiratory functions. Our study reveals
that a greater amount of CO2 gas was insufflated and
remained after ESD without the duodenal balloon, and it
affected patients’ symptoms (such as nausea) to some ex-
tent. We believe that the total insufflated CO2 gas vol-
ume should be controlled as little as possible whether or
not it may have an unfavorable effect on the human
body. A small CO2 gas volume is economical in terms ofdepicted: Case 5 (duodenal balloon group) and Case 36 (regular
er in the duodenal balloon group than in the regular group.
Figure 8 The VAS scores (0 to 10) for the occurrence of nausea
due to abdominal distension after ESD ranged from 0 to 1 in
the duodenal balloon group and from 3 to 7 in the regular
group, showing a significant difference between the two
groups (P=0.031).
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chasing CO2.
Second, massive insufflated CO2 gas may affect
patients’ blood gas analysis. In this study, changes in the
CO2 level during ESD were examined by PETCO2 as
measured by a capnometer that indirectly suggested the
arterial blood CO2 concentration [23]. In the duodenal
balloon group, the mean PETCO2 measured during ESD
(22.1 ± 4.74 mmHg) was significantly lower than that of
the regular group (46.6 ± 1.69 mmHg) (P= 0.0001). We
did not observe significant differences in ΔpH between
the two groups, but just after ESD in the regular group,
there was a significant difference in pH (P= 0.037). This
also implies that the arterial blood CO2 concentration
levels in the regular group during ESD were higher than
those of the balloon group. We sometimes perform ESD
under general anesthesia if it will take longer because
of the presence of a complicated lesion. When we per-
formed ESD for a prolonged period under general
anesthesia, some patients who underwent ESD with CO2
insufflation without the balloon showed dangerously
high CO2 concentration levels (around 60 mmHg) dur-
ing ESD. We were also advised that maintaining a high
PETCO2 level during ESD should be avoided to prevent
the risk of respiratory depression in patients with chronic
obstructive respiratory disease (COPD). Therefore, in
such COPD cases, the duodenal balloon method is pre-
ferable because it can maintain PETCO2 at low levels
during ESD.
Furthermore, during procedures such as laparoscopic
endoscopic cooperative surgery or hybrid natural orifice
transluminal endoscopic surgery [24], a clear operational
view without intestinal distension is helpful in obtaining
a good laparoscopic field of view in our hospital.Conclusions
CO2-insufflated ESD for early esophageal or gastric can-
cer was proven safe for early colorectal cancer. However,
the use of the duodenal balloon occlusion method in
ESD for early esophageal or gastric cancer may reduce
unnecessary insufflation of CO2 and prevent CO2 gas
from flowing into the intestine, which can maintain a
lower CO2 level in patients with COPD.
Limitations of this study were its single-center nature
and small sample size.
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